5 Results
Guidelines and Advice
Status: In-Review
ID: 1-19
ID: 1-19
Sep 2014
Guidelines and Advice
Status: Current
ID: GL-C50-11
ID: GL-C50-11
Jan 2014
Cancer facts
Drug
Other Name(s): Lupron® (AbbVie)
, Lupron Depot® (AbbVie)
, Eligard® (Sanofi Aventis)
Aug 2016